ESG in Obese Adolescents

NANot yet recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

January 31, 2028

Study Completion Date

January 31, 2030

Conditions
Obese AdolescentsObesity, MorbidObesity/Therapy
Interventions
DEVICE

Endoscopic Sleeve Gastroplasty (ESG) Procedure

The ESG procedure will be performed under general anesthesia monitored by an anesthesiologist. The device that will be used is called the Apollo Endosurgery ESG System, which is the only FDA approved device for the reduction of stomach volume through endoscopic sleeve gastroplasty for adult patients with obesity. This device works by being attached to a standard upper endoscope and is inserted through the mouth and goes into the stomach. When in the stomach, the back and front wall of the stomach will be stitched together to reduce the size of the stomach and help decrease the amount of food a patient can eat and drink at one time before feeling full.

Sponsors
All Listed Sponsors
collaborator

Boston Scientific Corporation

INDUSTRY

lead

Children's Hospital of Philadelphia

OTHER

NCT06914765 - ESG in Obese Adolescents | Biotech Hunter | Biotech Hunter